LOGIN  |  REGISTER

Recent Insider Transactions - ARS Pharmaceuticals (NASDAQ: SPRY)

Follow NASDAQ:SPRY Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
10/16/2024
Sell
$1.50
12,500
$19K
802,330
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
10/16/2024
Buy
$1.50
12,500
$19K
17,449
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
10/16/2024
Sell
$16.00
12,500
$200K
4,949
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$14.86
48,550
$722K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$15.25
1,450
$22K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$14.88
50,000
$744K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$14.86
48,550
$722K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$15.25
1,450
$22K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$14.88
50,000
$744K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
09/18/2024
Sell
$1.50
10,000
$15K
594,588
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
09/18/2024
Buy
$1.50
10,000
$15K
15,693
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
09/18/2024
Sell
$14.00
10,000
$140K
5,693
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
09/17/2024
Sell
$12.93
50,000
$647K
1.45M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
09/17/2024
Sell
$12.93
50,000
$647K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
09/17/2024
Sell
$12.93
50,000
$647K
1.45M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
09/17/2024
Sell
$12.93
50,000
$647K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
09/10/2024
Sell
$11.50
50,000
$575K
1.45M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
09/10/2024
Sell
$11.50
50,000
$575K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
09/10/2024
Sell
$11.50
50,000
$575K
1.45M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
09/10/2024
Sell
$11.50
50,000
$575K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Thompson Peter A. / director
08/26/2024
Sell
$13.00
83,695
$1.088M
0
NASDAQ SPRY ARS Pharmaceuticals
ORBIMED ADVISORS LLC / director
08/26/2024
Sell
$13.00
83,695
$1.088M
0
NASDAQ SPRY ARS Pharmaceuticals
Thompson Peter A. / director
08/21/2024
Sell
$13.52
394,400
$5.332M
557,977
NASDAQ SPRY ARS Pharmaceuticals
Thompson Peter A. / director
08/21/2024
Sell
$14.61
13,300
$194K
544,677
NASDAQ SPRY ARS Pharmaceuticals
Thompson Peter A. / director
08/22/2024
Sell
$12.94
391,482
$5.066M
153,195
NASDAQ SPRY ARS Pharmaceuticals
Thompson Peter A. / director
08/23/2024
Sell
$13.03
69,500
$906K
83,695
NASDAQ SPRY ARS Pharmaceuticals
ORBIMED ADVISORS LLC / director
08/21/2024
Sell
$13.52
394,400
$5.332M
557,977
NASDAQ SPRY ARS Pharmaceuticals
ORBIMED ADVISORS LLC / director
08/21/2024
Sell
$14.61
13,300
$194K
544,677
NASDAQ SPRY ARS Pharmaceuticals
ORBIMED ADVISORS LLC / director
08/22/2024
Sell
$12.94
391,482
$5.066M
153,195
NASDAQ SPRY ARS Pharmaceuticals
ORBIMED ADVISORS LLC / director
08/23/2024
Sell
$13.03
69,500
$906K
83,695
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
08/20/2024
Sell
$0.64
50,000
$32K
61,828
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
08/20/2024
Buy
$0.64
50,000
$32K
56,024
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
08/20/2024
Sell
$15.00
50,000
$750K
6,024
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
08/19/2024
Sell
$1.50
10,000
$15K
604,588
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
08/19/2024
Buy
$1.50
10,000
$15K
15,693
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
08/19/2024
Sell
$14.00
10,000
$140K
5,693
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
08/20/2024
Sell
$1.50
12,500
$19K
814,830
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
08/20/2024
Buy
$1.50
12,500
$19K
25,699
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
08/20/2024
Sell
$16.00
12,500
$200K
13,199
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
08/20/2024
Sell
$14.76
36,216
$534K
1.51M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
08/20/2024
Sell
$14.76
35,944
$530K
1.51M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
08/20/2024
Sell
$15.62
11,523
$180K
1.50M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
08/20/2024
Sell
$15.61
11,756
$184K
1.50M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
08/20/2024
Sell
$16.25
2,261
$37K
1.50M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
08/20/2024
Sell
$16.26
2,300
$37K
1.50M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
08/20/2024
Sell
$14.76
36,216
$534K
1.51M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
08/20/2024
Sell
$14.76
35,944
$530K
1.51M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
08/20/2024
Sell
$15.62
11,523
$180K
1.50M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
08/20/2024
Sell
$15.61
11,756
$184K
1.50M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
08/20/2024
Sell
$16.25
2,261
$37K
1.50M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
08/20/2024
Sell
$16.26
2,300
$37K
1.50M

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous